Associated Papers
Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In Vitro and In Vivo Preclinical Models.
Chan-Penebre E et al.
Molecular Cancer Therapeutics, 2017
28292935 (PubMed )
Supplement: 15357163mct160678-sup-4-14-2017_mct_supplemental_figures_resubmission_3.pdf
Select a paper to view details